Literature DB >> 2841081

Expression of coxsackievirus B3 capsid proteins in Escherichia coli and generation of virus-specific antisera.

S Werner1, W M Klump, H Schönke, P H Hofschneider, R Kandolf.   

Abstract

Subgenomic fragments of cloned infectious coxsackievirus B3 (CVB3) cDNA up to the size of the complete coding sequence of the viral polyprotein were inserted into the prokaryotic expression vector pPLc24 and expressed in Escherichia coli. Fusion proteins, containing 54 amino acids of MS2 replicase at their amino terminus followed by different parts of the CVB3 structural proteins, were expressed from several constructs. The expression product of a plasmid encoding the capsid proteins VP4, VP2, and the amino-terminal part of VP3 was obtained in high amounts. However, primary expression products containing the complete viral capsid precursor VP4-VP1 were completely degraded, indicating the presence of domains downstream from VP3 that are accessible to E. coli proteases. This finding is consistent with the observation that the structural intact expression product of the separately subcloned VP1 gene is also extremely unstable and consequently obtained only in low amounts. Two fusion proteins of non-overlapping parts of the viral structural proteins containing VP4, VP2, and VP3 or VP1, respectively, were isolated and used for the generation of antisera in rabbits. The antisera obtained recognize distinct CVB3 structural proteins in infected cell cultures as well as from purified CVB3 preparations. In addition, significant cross-reactivity of the described antisera with the corresponding structural proteins of other enteroviruses was observed, indicating that these antisera provide a valuable tool for an improved broad spectrum diagnosis of enteroviral infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841081     DOI: 10.1089/dna.1.1988.7.307

Source DB:  PubMed          Journal:  DNA        ISSN: 0198-0238


  17 in total

1.  Spectrum of monoclonal antibodies to coxsackievirus B-3 includes type- and group-specific antibodies.

Authors:  S Yagi; D Schnurr; J Lin
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  Efficient replication of recombinant Enterovirus B types, carrying different P1 genes in the coxsackievirus B5 replicative backbone.

Authors:  Nina Jonsson; Anna Sävneby; Maria Gullberg; Kim Evertsson; Karin Klingel; A Michael Lindberg
Journal:  Virus Genes       Date:  2015-02-08       Impact factor: 2.332

3.  Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera.

Authors:  B Y Reimann; R Zell; R Kandolf
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Role of enteroviruses in the pathogenesis of type 1 diabetes.

Authors:  M Roivainen; K Klingel
Journal:  Diabetologia       Date:  2009-03-26       Impact factor: 10.122

Review 5.  Viral heart disease.

Authors:  R Kandolf; P H Hofschneider
Journal:  Springer Semin Immunopathol       Date:  1989

6.  No evidence of enteroviruses in the intestine of patients with type 1 diabetes.

Authors:  A Mercalli; V Lampasona; K Klingel; L Albarello; C Lombardoni; J Ekström; V Sordi; A Bolla; A Mariani; D Bzhalava; J Dillner; M Roivainen; E Bosi; L Piemonti
Journal:  Diabetologia       Date:  2012-06-10       Impact factor: 10.122

7.  Tyrosine phosphorylation events during coxsackievirus B3 replication.

Authors:  M Huber; H C Selinka; R Kandolf
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 8.  Pancreatic pathology in type 1 diabetes mellitus.

Authors:  Sarah J Richardson; Noel G Morgan; Alan K Foulis
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

9.  A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity.

Authors:  Nicole Ettischer-Schmid; Andrea Normann; Martina Sauter; Lisa Kraft; Hubert Kalbacher; Reinhard Kandolf; Bertram Flehmig; Karin Klingel
Journal:  Virchows Arch       Date:  2016-08-27       Impact factor: 4.064

10.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation.

Authors:  K Klingel; C Hohenadl; A Canu; M Albrecht; M Seemann; G Mall; R Kandolf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.